Cite
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial
MLA
Aruna Acharyya, et al. “Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.” The Journal of Infectious Diseases, vol. 207, no. 12, Mar. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d8028c6c879862e198b0270ba237bb8&authtype=sso&custid=ns315887.
APA
Aruna Acharyya, Lindsey R. Baden, Shringkhala Bajimaya, David C. Fisher, Kelly Verrill, Ying Zhang, Joseph H. Antin, Marissa B. Wilck, Michael S. Seaman, Lisa S. Gagne, Raphael Dolin, David J. Dominguez, Jane A. Kleinjan, Stephen R. Walsh, Alka Patel, Heather Hill, & Elise Zablowsky. (2013). Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. The Journal of Infectious Diseases, 207(12).
Chicago
Aruna Acharyya, Lindsey R. Baden, Shringkhala Bajimaya, David C. Fisher, Kelly Verrill, Ying Zhang, Joseph H. Antin, et al. 2013. “Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.” The Journal of Infectious Diseases 207 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d8028c6c879862e198b0270ba237bb8&authtype=sso&custid=ns315887.